Thromb Haemost 1979; 42(03): 909-923
DOI: 10.1055/s-0038-1666940
Original Article
Schattauer GmbH Stuttgart

Comparative Histochemical Studies on Fibrinolysis in Whole Organs and Isolated Tissue Layers

Athanasios Smokovitis
The Gaubius Institute, Health Research Organization TNO, Leiden, The Netherlands
› Author Affiliations
Further Information

Publication History

Received 17 April 1978

Accepted 29 December 1978

Publication Date:
23 August 2018 (online)

Summary

Using Todd’s technique for the detection of plasminogen activator and Noordhoek Hegt and Brakman’s method for inhibitors of fibrinolysis, rat tissues were studied, both in sections of whole organs and as separated tissue layers. Whole organ preparations showed less fibrinolytic activity and poorer localisation of inhibitor, because of a widespread diffusion of the inhibitor from tissue layers rich in inhibitor during the histochemical procedures.

It is concluded that when using histochemical methods both agents are best studied in separated layers of the organ to avoid the masking effects of diffused inhibitor.

 
  • References

  • 1 Albrechtsen OK. 1957; a The fibrinolytic activity of human tissues. British Journal of Haematology 3: 284
  • 2 Albrechtsen OK. 1957; b The fibrinolytic activity of animal tissues. Acta Physiologica Scan- dinavica 39: 284
  • 3 Aoki N, Von Kaulla KN. 1971; Dissimilarity of human vascular plasminogen activator and human urokinase. Journal of Laboratory and Clinical Medicine 78: 354
  • 4 Åstedt B, Pandolfi M, Nilsson IM. 1971; Quantitation of fibrinolytic agents released in tissue culture. Experientia 27: 358
  • 5 Åstedt B. 1975; Fibrinolysis in cultured cells. Thrombosis et Diathesis Haemorrhagica 34: 644
  • 6 Astrup T. 1952; Ox lung tissue as a proteolytic inhibitor. Acta Physiologica Scandinavica 26: 243
  • 7 Astrup T, Stage A. 1952; Isolation of soluble fibrinolytic activator from animal tissue. Nature 170: 929
  • 8 Astrup T, Albrechtsen OK. 1957; Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues. Scandinavian Journal of Clinical Laboratory Investigation 9: 233
  • 9 Astrup T, Glas P, KOK P. 1968; Lung fibrinolytic activity and bovine mountain disease. Proceedings Society of Experimental Biology and Medicine 127: 373
  • 10 Barlow GH, Lazer L. 1972; Characterization of the plasminogen activator isolated from human embryo kidney cells: comparison with urokinase. Thrombosis Research 1: 201
  • 11 Beers WH, Strickland S, Reich E. 1975; Ovarian plasminogen activator: Relationship to ovulation and hormonal regulation. Cell 6: 387
  • 12 Bernik MB, Kwaan HC. 1967; Origin of fibrinolytic activity in cultures of the human kidney. Journal of Laboratory and Clinical Medicine 70: 650
  • 13 Bernik MB, Kwaan HC. 1969; Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study Journal of Clinical Investigation 48: 1740
  • 14 Bernik MB, Kwaan HC. 1971; Inhibitors of fibrinolysis in human tissues in culture. American Journal of Physiology 221: 916
  • 15 Bernik MB, White WF, Oller EP, Kwaan HC. 1974; Immunologic identity of plasminogen activator in human urine, heart, blood vessels and tissue culture. Journal of Laboratory and Clinical Medicine 84: 546
  • 16 Brakman P, Astrup T. 1971. The fibrin plate method for assay of fibrinolytic agents. In Bang NU, Beller FK, Deutsch E, Mammen EF. Eds Thrombosis and Bleeding Disorders. Academic Press; New York: 1971, pp 332
  • 17 Bratzler RL, Chisolm GM, Colton CK, Smith KA, Zilversmit DB, Lees RS. 1977; The distribution of labeled albumin across the rabbit thoracic aorta in vivo. Circulation Research 40: 182
  • 18 Cherry GW, Ellis JP, Kanan MW, Ryan TJ. 1975; Tissue fibrinolytic activity in skin following ischaemia. Bibliotheca Anatomica 13: 295
  • 19 Cole E, Bachmann F, Marchant L. 1976. Plasminogen activators from porcine tissue: Enzymatic and immunological properties. Third International Conference on Synthetic fibrinolytic thrombolytic agents. Glasgow: Sept. 1976 (Abstract No 5)
  • 20 Donner L, Klener P, Roth Z. 1977; The plasminogen activator of the arterial wall. Thrombosis and Haemostasis 37: 436
  • 21 Fischer A. 1930. Gewebeziichtung; München:
  • 22 Fleisher MS, Loeb L. 1915; On tissue fibrinolysis. Journal of Biological Chemistry 21: 477
  • 23 Glas-Greenwalt P. 1972. Latent and manifest endothelial fibrinolysis. Third Congress on “Thrombosis and Haemostasis”. Washington: 1972 (Abstract No 290)
  • 24 Huseby RM, Clavin SA, Smith RE, Hull RN, Smithwichk EL. 1977; Studies on tissue culture plasminogen activator. Thrombosis Research 10: 679
  • 25 Kwaan HC, Astrup T. 1967; Demonstration of cellular fibrinolytic activity by the histochemical fibrin slide technique. Laboratory Investigation 17: 140
  • 26 Laishes BA, Roberts E, Burrowes C. 1976; Fibrinolytic activity of adult rat liver cells in primary culture and inhibition by glucocorticoids. Biochemical Biophysical Research Communications 72: 462
  • 27 Liebermann J. 1968; Substrate specificity of plasminogen activator in the lungs of rabbits and rodents. Laboratory Investigation 19: 466
  • 28 Loskutoff D. 1977; Fibrinolytic components specified by vascular endothelial cells. Federation Proceedings 36: 676 (1977), (Abstract No. 2133)
  • 29 Nieuwenhuizen W, Wungaards G, Groeneveld E. 1977; Synthetic substrates and the discrimination between urokinase and tissue plasminogen activator activity. Thrombosis Research 11: 87
  • 30 Noordhoek Hegt V, Brakman P. 1974; a Histochemical study of an inhibitor of fibrinolysis in the human arterial wall. Nature 248: 75
  • 31 Noordhoek Hegt V, Brakman P. 1974; b Inhibition of fibrinolysis by the human vascular wall related to the presence of smooth muscle cells. Haemostasis 3: 118
  • 32 Noordhoek Hegt V. 1976; Distribution and variation of fibrinolytic activity in the walls of human arteries and veins. Haemostasis 5: 355
  • 33 Noordhoek Hegt V. 1977; a Relations between activation and inhibition of fibrinolysis in the walls of human arteries and veins. Thrombosis and Haemostasis 38: 407
  • 34 Noordhoek Hegt V. 1977; b Localization and distribution of fibrinolysis inhibition in the walls of human arteries and veins. Thrombosis Research 10: 121
  • 35 Onoyama K, Tanaka K. 1969; Fibrinolytic activity of the arterial wall. Thrombosis et Diathesis Haemorrhagica 21: 1
  • 36 Pandolfi M, Astrup T. 1967; A histochemical study of the fibrinolytic activity: cornea, conjunctiva and lacrimal gland. Archives Ophthalmology 77: 258
  • 37 Pandolfi M, Robertson V, Isacson S, Nilsson IM. 1968; Fibrinolytic activity of human veins in arms and legs. Thrombosis et Diathesis Haemorrhagica 20: 247
  • 38 Pandolfi M, Bjernstad A, Nilsson IM. 1972; Technical remarks on the microscopical demonstration of tissue plasminogen activator. Thrombosis et Diathesis Haemorrhagica 27: 88
  • 39 Pandolfi M, ÅStedt B, Nilsson IM. 1974; Direct observation of fibrinolysis in tissue culture. Thrombosis et Diathesis Haemorrhagica 31: 415
  • 40 Pelczar ME, Glas-Greenwalt P, Astrup T. 1972; Primary pulmonary aspergillosis with high fibrinolytic activity in the aortic intima. Chest 61: 394
  • 41 Pugatch E MJ, Poole JC F. 1969; Inhibitor of fibrinolysis from mésothélium. Nature 221: 269
  • 42 Pugatch EM J, Foster EA, MacFarlane DE, Poole JC F. 1970; The extraction and separation of activators and inhibitors of fibrinolysis from bovine endothelium and mésothélium. British Journal of Haematology 18: 669
  • 43 Roberts BI, White HJ, Read RC, Wagh PV. 1974; A new simplified procedure for the separation of aortic intima. Atherosclerosis 20: 533
  • 44 Ryan TJ, Nishioka K, Dawber RP R. 1971; Epithelial-endothelial interaction in the control of inflammation through fibrinolysis. British Journal of Dermatology 84: 501
  • 45 Smokovitis A, Kok P, Astrup T. 1975; Tissue repair in rats in presence of locally applied tissue plasminogen activator. Experimental Molecular Pathology 22: 109
  • 46 Smokovitis A, Kok P, Astrup T. 1976; a Presence of fibrin prolongs the retainment of locally injected tissue plasminogen activator. Experimental Molecular Pathology 24: 48
  • 47 Smokovitis A, Sugimoto M, Dannenberg Jr AM, Astrup T. 1976; b A histochemical study of the fibrinolytic activity in dermal tuberculous lesions produced by BCG in rabbits. Experimental Molecular Pathology 25: 236
  • 48 Smokovitis A, Astrup T. 1977; A histochemical study of fibrinolytic activity and inhibition of plasmin in the lungs of some animal species. Haemostasis 6: 318
  • 49 Smokovitis A. 1978; a Sex related fibrinolytic activity in rat tissues. Experientia 34: 483
  • 50 Smokovitis A. 1978; b Regions of constantly increased plasminogen activator activity along the intima of the normal aorta. Haemostasis 7: 303
  • 51 Smokovitis A, Astrup T. 1978; a Localization of fibrinolytic activity and inhibition of plasmin in the spinal cord of rat, guinea-pig and rabbit. Journal of Neurosurgury 48: 1008
  • 52 Smokovitis A, Astrup T. 1978; b Patterns of activation and inhibition of fibrinolysis in the normal skin of rat guinea-pig and rabbit. Journal of Investigative Dermatology 70: 321
  • 53 Smokovitis A, Astrup T. 1979 Fibrinolytic response to trauma and variation of activity in animal tissues normally low in fibrinolytic activity. Haemostasis. (in press)
  • 54 Smokovitis A, Astrup T. (submitted) Histochemical localization of plasminogen activator and inhibition of plasmin in peripheral nerves of the rat, guinea-pig and rabbit.
  • 55 Smokovitis A, Astrup T. (submitted) Plasminogen activator and neutral protease in the gastrointestinal tract of the rat, guinea-pig and rabbit.
  • 56 Todd AS. 1958; Fibrinolysis autographs. Nature 181: 495
  • 57 Todd AS. 1959; The histological localization of fibrinolytic activator. Journal of Pathology and Bacteriology 78: 281
  • 58 Todd AS. 1960. The tissue activator of plasminogen and thrombosis. In Walker W. (ed.) Thrombosis and anticoagulant therapy. Livingstone, Ltd; London: p 25
  • 59 Todd AS, Hargreaves LN Mc F. 1975. Identification of plasminogen activator in tissue. In Davidson JF, Samama MM, Desnoyers P C. Eds Progress in Chemical Fibrinolysis and Thrombosis. Raven Press; New York: 1975, Vol 1, p 217
  • 60 Todd AS, Hargreaves LN Mc F. 1976. Studies with antisera to plasminogen activator of vascular origin. Third International Conference on Synthetic fibrinolytic thrombolytic agents. Glasgow: Sept. 1976 (Abstract No. 6)
  • 61 Turner RH, Kurban AK, Ryan TJ. 1969; a Inhibition of fibrinolysis by human epidermis. Nature 223: 841
  • 62 Turner RH, Kurban AK, Ryan TJ. 1969; b Fibrinolytic activity in human skin following epidermal injury. Journal of Investigative Dermatology 53: 458
  • 63 Unkeless JC, Tobia A, Ossowski L, Quigley JP, Rifkin DB, Reich E. 1973; An enzymatic function associated with transformation of fibroblasts by oncogenic viruses I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. Journal of Experimental Medicine 137: 85
  • 64 Warren BA. 1963; Fibrinolytic properties of vascular endothelium. British Journal of Experimental Pathology 44: 365
  • 65 Warren BA, Khan S. 1975; The scanning electron microscopy of the lysis of fibrin by endothelium. British Journal of Experimental Pathology 56: 340
  • 66 Wunschmann-Henderson B, Astrup T. 1974; Inhibition by hydrocortisone of plasminogen activator production in rat tongue organ cultures. Laboratory Investigation 30: 427